Ethomix
Ethomix provides an AI-driven platform that uses wearable and remote sensing data to continuously monitor patient movement and discover digital biomarkers. This enables more sensitive and precise patient monitoring, which can significantly reduce clinical trial cohort sizes and trial length while supporting 24/7 patient state assessment in hospitals and home care. The company has a 50-terabyte repository of daily-life behavioral data and published research in Nature Medicine.
- Healthcare Technology
- Digital Health
- Artificial Intelligence
- Internet of Things
- Software Only
- Data & Analytics
- Drug Discovery & Therapeutics
- Hardware
- Medical Devices
Funding
Founders
Founder details are not available yet.
Product
Problem
Traditional patient monitoring in clinical trials and hospital settings relies on sporadic, subjective assessments that fail to capture the full picture of a patient's condition. This approach often leads to delayed detection of deterioration, requires larger cohort sizes to achieve statistical significance, and extends trial timelines, ultimately slowing down the delivery of new treatments to patients.
Solution
Ethomix provides a comprehensive platform that uses AI and wearable technology to monitor patients continuously in their daily lives. The company captures movement data from wearables and remote sensing, then applies state-of-the-art machine learning to discover and validate digital biomarkers. This enables more precise and sensitive patient monitoring, which can dramatically reduce clinical trial cohort sizes and trial length while also providing 24/7 attention to patient state in hospital and home care settings. The platform offers a complete package for remote monitoring, supporting both clinical trials and ongoing patient care with higher precision and broader coverage than traditional methods.
Target Audience
Primary customers are pharmaceutical companies running clinical trials, healthcare providers monitoring patients in hospital wards, and home care organizations supporting assisted living environments.
Features
- AI-powered digital biomarker discovery from wearable and human movement data
- 50 terabyte repository of daily-life natural behavioral data for model training
- International patents covering digital biomarkers and medical device technology
- Validated technology with publications in Nature Medicine and completed clinical trials across multiple diseases
- Remote monitoring capabilities supporting 24/7 patient state assessment
- Application across drug development, clinical trials, in-ward monitoring, and assisted living